Delivery Order SPE2DB24D2013-SPE2DB25FCJTD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,281.58 to AmerisourceBergen Drug Corp for Icosapent Ethyl 1 gram capsules (120-count package), with an ultimate completion date of July 28, 2025. This non-competitive, competitively awarded delivery order represents a firm fixed price procurement supporting federal medical supply requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing this work at...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Icosapent Ethyl 1 Gram Capsule 120s, with a ceiling value of $2,053.92 and a completion date of June 10, 2025. The contract is not set aside and is an open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,420.97 firm-fixed-price delivery order is for the supply of Icosapent Ethyl 1 gram capsules, a cardiovascular medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,374.04 firm fixed-price delivery order is for the supply of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a cardiovascular medication, to support military healthcare programs. The contract has an ultimate completion date of November 28, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award, valued at $2,664.83, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Icosapent Ethyl 1 gram capsules (120 count). The award has a completion date of January 31, 2023 and is structured as a firm fixed-price delivery order. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp, a for-profit organization registered in the System for Award...
- This federal contract award, valued at $1,232.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a cardiovascular medication. This is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S. The $2,382.04 firm-fixed-price delivery order has an ultimate completion date of April 9, 2024. AmerisourceBergen holds two Indefinite Delivery Contracts (IDCs) with the government - one with the DLA Troop Support Medical valued at $999,999,999 through November 2026, and another with the...
- The federal contract award SPE2DB20D3505|SPE2DB23FT6H4 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,412.31 fixed-price delivery order is for the supply of 4559771141 - Icosapent Ethyl 1 Gram Capsule 120s, with a completion date of January 31, 2023. This award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract is for the delivery of ICOSAPENT ETHYL 1 GRAM CAPSULE 120S, a pharmaceutical product, with a potential value of $4,030.68. The contract has a firm fixed price pricing type and a completion date of January 9, 2024. No set-aside designation was used. Amerisourcebergen...
- This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $6,229.78 for the pharmaceutical product Icosapent Ethyl 1 gram capsules. The contract was awarded by the Defense Logistics Agency (DLA) on January 20, 2023, with a completion date of January 23, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which...
- SPE2DB24D2013Indefinite Delivery Contract
- SPE2DB24D2013-SPE2DB25FCJTDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Icosapent Ethyl 1 gram capsules (120-count) with a ceiling value of $14,335.03. This firm fixed-price delivery order, which is not set-aside designated, is scheduled for ultimate completion on July 29, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Icosapent ethyl is a prescription medication used for cardiovascular health management, and this delivery supports the military's pharmaceutical supply chain requirements. This delivery order is a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor, AmerisourceBergen supplies a comprehensive range of medications and medical products to support military healthcare programs globally. The competitively awarded IDC serves as a flexible vehicle enabling the company to deliver brand-name and generic pharmaceuticals, vaccines, and specialized medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.3k | 7/28/25 |